The company operates as a publicly held company. Commencing operations on 21 Jun 2006, it specializes in the manufacture of pharmaceuticals, medicinal chemical and botanical products sector, providing a wide array of products and services. The sales of the company are downtrend, while the CAGR for the manufacture of pharmaceuticals, medicinal chemical and botanical products industry has been decreasing 2.80% in recent years.
The financial statement reveals that, charter capital of the company is VND 113,643,250,000, TRAPHACO HIGH TECH JOINT STOCK COMPANY is adequately funded to sustain its business activities. Strategic direction is overseen by MA T.H and NGUYEN D.K and TRAN T.B.N and VU N.L and NGUYEN V.N, who plays a pivotal role in shaping company policies.